

3 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| Asset Management Ventures V | March 2020 | $150M | $33M | 10 |
| Asset Management Ventures IV | September 2015 | $100M | $25M | 0 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
3 partners are named across this firm’s filings, 3 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| David Fleshman | Slowing | Digital health | 5 | 1 |
| Louis Lange | Quiet | Biotech & pharma | 4 | 0 |
| Richard Simoni | Quiet | Cybersecurity, E-commerce & marketplaces | 4 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Classified sectors of Asset Management Ventures’s own portfolio companies, based on 8 with a verified or cited source.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Asset Management Ventures’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Firm | Shared boards | Companies |
|---|---|---|
| 270 Healthcare Growth | 1 | Audentes Therapeutics |
| Battery Ventures | 1 | Reify Health |
| Caduceus Capital | 1 | Audentes Therapeutics |
| Dangerous Ventures | 1 | Reify Health |
| ff Venture Capital | 1 | UNIKEY TECHNOLOGIES |
| Floodgate | 1 | KEEPSAFE SOFTWARE |
| Longitude Capital | 1 | CARDIODX |
| Orbimed Genesis | 1 | Audentes Therapeutics |
| Sierra Ventures | 1 | Reify Health |
| Versant Venture Capital | 1 | Audentes Therapeutics |
A shared board seat: a company where filings name a Asset Management Ventures partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.